Literature DB >> 18430038

Bilateral macular sub-retinal fluid and retinal pigment epithelial detachment associated with type 2 membrano-proliferative glomerulonephritis.

Muhammad Amer Awan1, David J Grierson, S Walker.   

Abstract

Choroidal neovascularisation (CNV) and idiopathic central serous chorioretinopathy (ICSC) are recognised ocular complications related to type 2 membrano-proliferative glomerulonephritis. We report a 38-year-old white male who presented with a 10-day history of blurring of vision, micropsia and metamorphopsia. He had been diagnosed recently to have type 2 membrano-proliferative glomerulonephritis. On examination, there was bilateral retinal pigment epithelial (RPE) detachment with overlying sub-retinal fluid without any drusen. Fundus fluorescein angiography (FFA) and optical coherence tomography (OCT) confirmed the diagnosis of atypical ICSC. Three months later, sub-retinal fluid and RPE detachment resolved and VA had recovered to 6/6. The case highlights the importance of ophthalmological assessment in these patients to recognise sight-threatening complications.

Entities:  

Mesh:

Year:  2008        PMID: 18430038     DOI: 10.1111/j.1444-0938.2008.00268.x

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  4 in total

1.  [Differential diagnosis and therapy of pigment epithelial detachment].

Authors:  M A Gamulescu; H Helbig; J Wachtlin
Journal:  Ophthalmologe       Date:  2014-01       Impact factor: 1.059

2.  [Patient with type II membranoproliferative glomerulonephritis: intravitreal bevacizumab therapy for choroidal neovascularization].

Authors:  M Karampelas; N Kopsachilis; J H Chang; B Pal
Journal:  Ophthalmologe       Date:  2012-08       Impact factor: 1.059

Review 3.  Multimodal imaging of retinal pigment epithelial detachments in patients with C3 glomerulopathy: case report and review of the literature.

Authors:  Valeria Kheir; Ali Dirani; Matthieu Halfon; Jean-Pierre Venetz; Georges Halabi; Yan Guex-Crosier
Journal:  BMC Ophthalmol       Date:  2017-11-22       Impact factor: 2.209

4.  Systemic complement activation in central serous chorioretinopathy.

Authors:  Elon H C van Dijk; Roula Tsonaka; Ngaisah Klar-Mohamad; Diana Wouters; Aiko P J de Vries; Eiko K de Jong; Cees van Kooten; Camiel J F Boon
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.